Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19
We offer a fast and efficient diagnostic method which can be applied to a large amount of tests in a short time.
Our method is based on a kit which identifies specifically the viral RNA biomarker.
The test is characterized by reliability, sensitivity, rapid (not more than 10-15 minutes), low toxicity and reasonable cost.
Project ID : 47-2020-10881
Description of the technology
Project manager
Keren-Or Amar
VP, Business Development, Healthcare
Project researchers
Eylon Yavin
HUJI, School of Medicine - IMRIC
School of Pharmacy- Institute for Drug Research
Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.
Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.
Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.
Create your free account to connect with Covid-19 Innovation Challenges by Innoget and thousands of other innovative organizations and professionals worldwide
Send a request for information
to Covid-19 Innovation Challenges by Innoget
Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.
Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support
